ClinicalTrials.Veeva

Menu

Impact of 5-fraction Stereotactic Partial Breast Irradiation and Whole Breast Irradiation on Cosmetic Outcome and Patient-reported Outcomes in Early-stage Breast Cancer

Yonsei University logo

Yonsei University

Status

Unknown

Conditions

Breast Cancer

Treatments

Radiation: Whole breast irradiation
Radiation: Partial breast irradiation

Study type

Observational

Funder types

Other

Identifiers

NCT03568981
4-2018-0160

Details and patient eligibility

About

This study aim to investigate the effect of 5-fraction stereotactic partial breast irradiation and whole breast irradiation on patient-reported outcomes, cosmetic outcome, and breast tissue fibrosis in early-stage breast cancer.

Enrollment

200 estimated patients

Sex

Female

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pathologically confirmed invasive breast carcinoma or ductal carcinoma in situ (DCIS)
  • Women who underwent breast-conservating surgery and have a plan to undergoing partial or whole breast irradiation
  • Good performance status (ECOG 0-1)

Exclusion criteria

  • Recurrent breast cancer
  • History of ipsilateral breast irradiation
  • Positive resection margin status after breast surgery

Trial design

200 participants in 2 patient groups

Partial Breast Irradiation (PBI)
Description:
Patients receiving 5-fraction stereotactic partial breast irradiation for breast cancer
Treatment:
Radiation: Partial breast irradiation
Whole Breast Irradiation (WBI)
Description:
Patients receiving whole breast irradiation for breast cancer
Treatment:
Radiation: Whole breast irradiation

Trial contacts and locations

1

Loading...

Central trial contact

Yong Bae Kim, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems